Philip Morris International INC 8-K filings

NYSE
Philip Morris International (PMI) has announced the issuance of $2.5 billion in aggregate principal amount of new notes with varying interest rates and maturity dates.
NYSE
Philip Morris International (PMI) announced strong first-quarter 2025 results, driven by smoke-free product growth, and raised its full-year adjusted diluted EPS forecast.
NYSE
Philip Morris International updates segment reporting to include Wellness & Healthcare results in the Europe segment and renames PMI Duty Free to PMI Global Travel Retail, recasting historical financials to reflect these changes.
NYSE
Philip Morris International's Canadian affiliate, Rothmans, Benson & Hedges Inc., receives court approval for a plan resolving all tobacco product-related claims and litigation in Canada.
NYSE
Philip Morris International announces a regular quarterly dividend of $1.35 per common share, payable on April 10, 2025, to shareholders of record as of March 20, 2025.
NYSE
Philip Morris International outlines its strategy to transition to a smoke-free future, targeting significant growth in smoke-free products and improved financial performance.
NYSE
Philip Morris International reaffirms its 2025 full-year reported diluted EPS forecast of $6.55 to $6.68 during the Consumer Analyst Group of New York (CAGNY) Conference.
NYSE
Philip Morris International (PMI) announces robust 2024 financial results, fueled by growth in smoke-free products like IQOS and ZYN, with adjusted diluted EPS of $6.57, representing a 9.3% increase.
NYSE
The FDA has authorized all ZYN nicotine pouch products currently marketed by Swedish Match in the U.S., making them the first authorized nicotine pouch in the country.
NYSE
Philip Morris International completed the sale of its subsidiary Vectura Group Ltd. to Molex Asia Holdings Ltd. on December 31, 2024, as previously announced.
NYSE
Philip Morris International has entered into a new credit agreement for a $1.6 billion revolving credit facility to be used for general corporate purposes.
NYSE
Philip Morris International has declared a regular quarterly dividend of $1.35 per common share, payable on January 13, 2025, to shareholders of record as of December 26, 2024.
NYSE
Philip Morris International prepaid approximately $3.2 billion of its senior unsecured term loan, utilizing proceeds from a recent note issuance and cash on hand.
NYSE
Philip Morris International has issued $3 billion in new debt through four tranches of senior unsecured notes to be used for general corporate purposes and debt repayment.
NYSE
Philip Morris International reported strong third-quarter results, leading to an increased full-year earnings outlook.
NYSE
Philip Morris International's deconsolidated Canadian affiliate, Rothmans, Benson & Hedges Inc., is involved in a proposed plan to resolve tobacco-related litigation with a potential settlement of approximately $23.5 billion.
NYSE
Philip Morris International has agreed to sell its subsidiary Vectura Group to Molex Asia Holdings for an upfront payment of approximately $198 million, with potential for an additional $195 million in milestone payments.
NYSE
Philip Morris International has announced a 3.8% increase in its quarterly dividend, raising it to $1.35 per share.
NYSE
Philip Morris International reaffirmed its full-year 2024 earnings forecast, projecting a currency-neutral growth of 11% to 13% in adjusted diluted EPS.
NYSE
Philip Morris International announced a robust second quarter performance driven by its smoke-free business, leading to an increase in full-year guidance despite currency headwinds.
NYSE
Philip Morris International's affiliate, Swedish Match North America, received a subpoena from the Attorney General of the District of Columbia regarding the sale of flavored ZYN nicotine pouches.
NYSE
Philip Morris International declared a regular quarterly dividend of $1.30 per common share, payable on July 8, 2024, to shareholders of record as of June 21, 2024.
NYSE
Philip Morris International has successfully issued $500 million in 3.750% notes due in 2031, with the proceeds intended for general corporate purposes.
NYSE
Philip Morris International has increased its full-year 2024 reported diluted EPS forecast due to favorable currency exchange rates, while maintaining its currency-neutral adjusted diluted EPS growth forecast of 9.0% to 11.0%.
NYSE
Philip Morris International held its annual shareholder meeting on May 8, 2024, electing all director nominees and approving executive compensation and auditor ratification.
NYSE
Philip Morris International held its 2024 Annual Meeting of Shareholders, showcasing strong progress in its smoke-free transformation and business performance.
NYSE
Philip Morris International announced a strong first quarter in 2024, with significant growth in smoke-free products and an increase in adjusted diluted EPS, leading to an improved full-year outlook.
NYSE
Philip Morris International declared a regular quarterly dividend of $1.30 per common share, payable on April 9, 2024, to shareholders of record as of March 21, 2024.
NYSE
Philip Morris International is updating its segment reporting to integrate Swedish Match results into its existing geographical segments, effective from the first quarter of 2024.
NYSE
Philip Morris International reaffirmed its full-year 2024 earnings forecast and discussed its progress towards becoming a smoke-free business at the Consumer Analyst Group of New York Conference.